Bionano Genomics, Inc. 8-K Report: Key Updates as of January 15, 2025
Based on the provided section of the financial report, the following key information and insights can be extracted:
- Company Information:
- Name: Bionano Genomics, Inc.
- CIK: 0001411690
- State of Incorporation: Delaware (DE)
- SEC Central Index Key (CIK): 0001411690
- Stock Exchange: NASDAQ
- Ticker Symbol: BNGO
- Address: 9540 Towne Centre Drive, Suite 100, San Diego, CA 92121
- Phone Number: 858-888-7600
- Filing Details:
- Form Type: 8-K (This form is used to report unscheduled material events or corporate changes that could be of importance to shareholders.)
- Filing Date: January 15, 2025
- Period Covered: January 15, 2025 (This indicates a specific date rather than a range, which is common in 8-K filings.)
- Stock Information:
- Common Stock Par Value: $0.0001 per share
- Other Notes:
- The document uses XML and XBRL format, indicating it is structured for financial reporting and compliance with SEC regulations.
- The presence of a schema reference (
bngo-20250115.xsd) suggests that the filing adheres to a specific format for data interpretation.
Insights:
- The filing is a current report (Form 8-K), which means it likely contains important information that could affect the stock price or investor decisions regarding Bionano Genomics, Inc.
- The specific date of January 15, 2025, indicates that this report may contain timely information about events or developments occurring on that date.
- The low par value of the common stock ($0.0001) is typical for many biotech companies, suggesting a high potential for volatility in share price.
This information serves stakeholders by offering a snapshot of the company's current status and compliance with SEC reporting requirements.